Daily as of 2 Nov 16:00 ET
- Price
- above both $11.00 vs 50 $10.97 / 200 $9.54
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 2 Dec 2025 · projected 15 bars out · tested 2 bars
VIR | Vir BiotechnologyNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$11.00
-$0.30 (-2.65%)
Vir Biotechnology (VIR) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2020.
The 50 SMA has sat above the 200 on the daily since Dec 2025, with no cross projected inside the 30 bars Cruxta tracks. Price sits above the 50 and the 200 on the daily, the weekly and the 4-hour.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- above both $11.30 vs 50 $8.87 / 200 $10.83
- Projection
- 🟨Golden cross projected in 13 bars
- Test
- No active test
- Last cross
- No cross on record
4-hour as of 3 Nov 16:00 ET
- Price
- above both $11.22 vs 50 $11.05 / 200 $10.19
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 1 Sep 2026 · projected 30 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 1 Sep 2026 | 🟨Golden | 4-hour | 30 bars out | Not tested |
| 5 Aug 2026 | 💀Death | 4-hour | 18 bars out | 1 bar cross test |
| 8 Jul 2026 | 🟨Golden | 4-hour | 3 bars out | 2 bar cross test |
| 6 Jul 2026 | 💀Death | 4-hour | 1 bar out | Not tested |
| 29 Jun 2026 | 🟨Golden | 4-hour | 8 bars out | Not tested |
About VIR
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$18.8M
4-hour coverageYes, since Oct 2025
History on recordSince 2020
SectorHealthcare
Cap bandsmall